ISBN: 978-80-244-6668-2 | ISBN online: 978-80-244-6669-9 | DOI: 10.5507/prf.25.24466682

Chemické látky a jejich biologické účinky

Pavel Hradil, Miroslav Soural


The book is focused on a wide range of chemicals and their biological effects. Most attention is paid to pharmaceuticals, where both older substances and newly marketed substances are shown. Another smaller group of substances described are pesticides followed by warfare agents. In addition to the chemical structure, the use of the compound, the basic mechanism of action and the company that developed the product are presented. In a supplementary chapter, attention is given to toxic substances. In addition to historical natural substances, important toxic or health hazardous industrial intermediates and wastes are listed.  In all sections, important time data are given to give the reader an idea of how long some substances have been in use or how long it has taken to bring a new compound to market since its discovery. Practical examples are used to show how the development of one group is transferred and transformed into another. For example, the discovery of warfare agents, leads to the development of new groups of insecticides and subsequently drugs.

1. edition, Published: 2025, online: 2025, publisher: Univerzita Palackého v Olomouci, Křížkovského 8, 771 47 Olomouc



References

  1. O´Neil M. J. et al.: The Merck Index, The Royal Society of Chemistry, 15th ed., 2013, Cambridge.
  2. Vymazal T.: Klin. Farmakol. Farm. 2019, 33, 11-14. Go to original source...
  3. Kreigová M.: Zelená medicína, Orbis Praha, 1970.
  4. Kunz E.: Dialog. Clin. Neurosci. 2014, 16, 113-7; DOI:10.31887/DCNS.2014.16.1/ekunz. Go to original source...
  5. Kopeček M.: Remedia 2002, 164; https://www.remedia.cz/rubriky/lekove-profily/amisulpridum-968/.
  6. Crilly J.: History of Psychiatry 2007, 18, 39- 60; DOI: 10.1177/0957154X07070335. Go to original source...
  7. https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/4178-12-new-findings-on-quetiapine; staženo 3.12.2024.
  8. https://morrisdewett.com/the-story-behind-risperdal/; staženo 3.12.2024.
  9. https://www.fda.gov/news-events/press-announcements/fda-approves-drug-new-mechanism-action-treatment-schizophrenia; staženo 3.12.2024.
  10. https://mkn10.uzis.cz/prohlizec/F32; staženo 3.12.2024. Go to original source...
  11. Fujáková M, Kopeček M.: Klinická farmakologie a farmacie 2012, 26, 29; https://www.klinickafarmakologie.cz/pdfs/far/2012/01/06.pdf; staženo 3.12.2024.
  12. https://www.drugs.com/drug-class/tricyclic-antidepressants.html; staženo 3.12.2024.
  13. Stone T. et al.: Léky, Drogy, Jedy, Academia, 2000.
  14. Lancaster S. G. et.al.: Drugs 1989, 38, 123-147; https://doi.org/10.2165/00003495-198938010-00005. Go to original source...
  15. Pereira V. S. et al.: Acta Neuropsychiatrica 2018, 30, 307-322; DOI:10.1017/neu.2017.39. Go to original source...
  16. Ruffalo M. L.: Psychology today 2000; https://www.psychologytoday.com/us/blog/freud-fluoxetine/202003/the-story-prozac-landmark-drug-in-psychiatry; staženo 4.12.2024.
  17. Látalová K. Pidrman V.: Klin. Farmakol. Farm. 2004, 18, 218-222; https://www.klinickafarmakologie.cz/pdfs/far/2004/04/08.pdf; staženo 3.12.2004.
  18. Lopez-Ibor J. et al.: International Clinical Psychopharmacology 1996, 11, 41-46; DOI: 10.1097/00004850- 199609004-00006. Go to original source...
  19. Tůma I.: Remedia 2005, 16, 559-562; https://www.remedia.cz/rubriky/aktuality/duloxetin-treti-antidepresivum-skupiny-snri-716/; staženo 2.12.2004.
  20. Žourková A.: Remedia 2007, 17, 572-594; https://www.remedia.cz/rubriky/aktuality/bupropion-vice-nez-antidepresivum-1163/; staženo 3.12.2004.
  21. https://pubmed.ncbi.nlm.nih.gov/22232986/, staženo 4.12.2024.
  22. https://pubmed.ncbi.nlm.nih.gov/31678098/; staženo 4.12.2024.
  23. https://www.cbsnews.com/news/anti-depressant-taken-off-market/; stažno 4.12.2024.
  24. https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2023, staženo 4.12.2024.
  25. Raison C. L. et al.: JAMA 2023, 330, 843-853; DOI:10.1001/jama.2023.14530. Go to original source...
  26. Walsh C. A. et al.: JAMA Psychiatry 2024, 81, 89-96; DOI:10.1001/jamapsychiatry.2023.3867. Go to original source...
  27. Agranoff B. W: Neuropsychopharmacology 2008, 33, 3251; DOI: 10.1038/npp.2008.100. Go to original source...
  28. Tetreault L. et al.: Can Med Assoc J. 1967, 97, 395-8; https://pmc.ncbi.nlm.nih.gov/articles/PMC1923261/?page=1; staženo 5.12.2024.
  29. https://www.drugs.com/monograph/buspirone.html; staženo 5.12.2024.
  30. Wick J.: The Consultant Pharmacist 2013, 538-548; DOI: 10.4140/TCP.n.2013.538. Go to original source...
  31. Ait-Daoud N. et al.: J. Addict Med. 2018, 12, 4-10; DOI:10.1097/ADM.0000000000000350. Go to original source...
  32. https://go.drugbank.com/drugs/DB01205; staženo dne 5.12.2024.
  33. Shorter E.: Nat Rev Drug Discov 2002, 1, 1003-1006; DOI:10.1038/nrd964. Go to original source...
  34. von Boxberg C. et al.: Dtsch Med. Wochenschr. 1998, 123, 866-70; https://pubmed.ncbi.nlm.nih.gov/9693657/; staženo 5.12.2024. Go to original source...
  35. Morselli P. L.: Pharmacopsychiatry 1990, 23, 129-134; DOI: 10.1055/s-2007-1014549 Go to original source...
  36. https://go.drugbank.com/drugs/DB00557; staženo 5.12.2024.
  37. McClure-Begley T. D. et al.: Nat. Rev. Drug Discov. 2022, 21, 463-473; DOI:10.1038/s41573-022-00421-7. Go to original source...
  38. Reiff C. M. et al.: Am. J. Psychiatry 2019, 177, 391-410; DOI:10.1176/appi.ajp.2019.19010035. Go to original source...
  39. https://www.prevcentrum.cz/informace-o-drogach/lsd/; staženo 7.12.2024.
  40. https://www.extc.cz/informace/lysohlavky-psylocibin; staženo 7.12.2024.
  41. https://www.mescaline.com/exp/index.htm; staženo 7.12.2024.
  42. Carbonaro T. M. et al.: Brain Res. Bull. 2016, 126, 74-88. DOI:10.1016/j.brainresbull.2016.04.016. Go to original source...
  43. Noble C. et al.: Toxicolology Lett. 2018, 295, 397-407; DOI:10.1016/j.toxlet.2018.07.018. Go to original source...
  44. https://www.vumc.org/poison-control/toxicology-question-week/april-26-2016-what-bro-mo-dragonfly; staženo 9.12.24.
  45. Harding W. W. et.al.: J. Nat. Prod. 2006, 69, 107-12; DOI: 10.1021/np050398i. Go to original source...
  46. https://www.erowid.org/library/books_online/salvinorin/fx.shtml; staženo 9.12.24.
  47. Giannini A. J. et al.: J. Tox. Clin. Tox. 1984, 22, 573-579; DOI:10.3109/15563658408992586 Go to original source...
  48. Snyder S. H.: Nature 1980, 285, 355-356; DOI:10.1038/285355a0. Go to original source...
  49. Zinkand W. et al. Mol. Chem. Neuropathology 1992, 16, 1-10; DOI:10.1007/bf03159956. Go to original source...
  50. Michelot D. et al.: Mycol. Res. 2003, 107, 131-146; DOI: 10.1017/S0953756203007305. Go to original source...
  51. Kotz A. et al.: J. Prakt. Chem. 1926, 113, 49. Go to original source...
  52. https://www.justice.gov/archive/ndic/pubs4/4440/index.htm; staženo 9.12.2024.
  53. Zanos P. et al.: Pharmacol Rev. 2018, 70, 621-660; DOI:10.1124/pr.117.015198. Go to original source...
  54. Hirota K. et al.: British J. Anest. 1996, 77, 441-444; DOI: 10.1093/bja/77.4.441. Go to original source...
  55. https://en.wikipedia.org/wiki/Deliriant; staženo 9.12.24.
  56. https://web.archive.org/web/20220419151844/https://www.woodlibrarymuseum.org/wp-content/uploads/e-books/w0012pdf.PDF; staženo 9.12.24.
  57. https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2013.3386;staženo 9.12.24.
  58. https://medlineplus.gov/druginfo/meds/a684010.html; staženo 9.12.24.
  59. Patočka J. et al.: Mil. Med. Sci. Lett. 2017, 86, 58-69; DOI: 10.31482/mmsl.2017.010. Go to original source...
  60. https://www.stickygarden.cz/blog/muscimol-ucinky-a-predavkovani/; staženo 9.12.2024.
  61. https://pubchem.ncbi.nlm.nih.gov/compound/4266; staženo 9.12.2024.
  62. https://en.wikipedia.org/wiki/3-Quinuclidinyl_benzilate; staženo 9.12.2024.
  63. Lattová Z.: Psychiat. pro Praxi 2009, 10, 125-129; www.psychiatriepropraxi.cz/pdfs/psy/2009/03/05.pdf; staženo 11.12.2024.
  64. Davies M.: J. Psychiatry Neurosci. 2003, 28, 263-74; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165791/; staženo dne 11.12.2024. Go to original source...
  65. Schaffarzick R. W. et al.: Science 1952, 116, 663; DOI: 10.1126/science.116.3024.663. Go to original source...
  66. Weaver L. C. et al.: Arch Int Pharmacodyn Ther. 1961, 131, 116-22; https://pubmed.ncbi.nlm.nih.gov/13783544/; staženo 11.12.2024.
  67. https://www.drugs.com/cons/ethchlorvynol.html; staženo 11.12.2024.
  68. Greenblatt D. J. et al.: Ann Intern Med. 1972, 77, 91-100; DOI:10.7326/0003-4819-77-1-91. Go to original source...
  69. New Eng. J. Med. 1956, 255, 909-910; DOI:10.1056/NEJM195611082551910. Go to original source...
  70. https://go.drugbank.com/drugs/DB09117; staženo 11.12.2024.
  71. Rádl S.: Příběhy spojené s objevy nových léčiv II, VŠCHT Praha, 2025.
  72. https://cs.wikipedia.org/wiki/Barbitur%C3%A1ty; staženo 11.12.2024.
  73. Gorodetsky R.: Encyclopedia of Toxicology Elsevier Inc.; 3th ed, 2014; ISBN 978-0-12-386455-0.
  74. https://drugs.ncats.io/drug/57DQA39DO2; staženo 12.12.2024.
  75. https://pubchem.ncbi.nlm.nih.gov/compound/6292.
  76. https://www.thalidomidetrust.org/about-us/about-thalidomide/; staženo 12.12.2024.
  77. https://go.drugbank.com/categories/DBCAT003883.
  78. https://www.justice.gov/archive/ndic/pubs6/6074/6074p.pdf; staženo 12.12.2024.
  79. Roth T.: Pharmacotherapy 1983, 3, 137-48; DOI: 10.1002/j.1875-9114.1983.tb03237.x. Go to original source...
  80. https://www.internimedicina.cz/pdfs/int/2005/09/06.pdf.
  81. Benavide J. et al.: Encephale 1990, 16, 13-22; https://pubmed.ncbi.nlm.nih.gov/2158421/; staženo 12.12.24.
  82. Kuriyama A. et al: Sleep Med. 2014, 4, 385-392; DOI: 10.1016/j.sleep.2013.11.788. Go to original source...
  83. Kripke D. F.: F1000Res. 2015, 456, 1-14; DOI:10.12688/f1000research.6845.1. Go to original source...
  84. De Crescenzo F. et al.: Lancet 2022, 400, 170-184;DOI:10.1016/S0140-6736(22)00878-9. Go to original source...
  85. Kim H. J. at al.: Int. Rev. Neurobiol. 2017, 132, 295-343; DOI: 10.1016/bs.irn.2017.01.006. Go to original source...
  86. Annus Á. et al.: Drug Design, Dev. Ther. 2017, 11, 143-151; DOI: 10.2147/DDDT.S104227. Go to original source...
  87. Jawad F. et al.: J. Clinical Investigation 2023, 133, 1-17; https://www.jci.org/articles/view/161142/pdf; staženo 17.12.2024.
  88. Miller R. et al.: Cochrane Database Syst. Rev. 2012, 1-34; DOI:10.1002/14651858.CD001447.pub3. Go to original source...
  89. https://cureparkinsons.org.uk/ambroxol-the-story-behind-the-medicine/; staženo 17.12.2024.
  90. https://go.drugbank.com/drugs/DB00252; staženo 17.12.2024.
  91. Graeme J. S.: https://epilepsysociety.org.uk/sites/default/files/2020-08/Chapter25Sills2015.pdf; staženo 17.12.2024.
  92. Henry T. R.: Psychopharmacol. Bull. 2003; 37; Suppl 2; 5-16; PMID: 14624229. Go to original source...
  93. https://synapse.patsnap.com/article/what-is-the-mechanism-of-gabapentin; staženo 29.12.2024.
  94. https://go.drugbank.com/drugs/DB00909, staženo 17.12.2024.
  95. Katzung B. G. Základní & klinická farmakologie, H & H, 1994.
  96. Brázdil M.: Cesk. Slov. Neurol. 2022, 85, 417-420; https://www.csnn.eu/casopisy/ceska-slovenska-neurologie/2022-5-7/cenobamat-132519;staženo17.12.2024.
  97. https://euc.cz/clanky-a-novinky/clanky/migrena-priciny-prubeh-a-lecba/.
  98. https://migrainecanada.org/posts/the-migraine-tree/branches/acute-treatments/the-fascinating-history-of- triptans/; staženo 18.12.2024.
  99. Nežádal T.: Klin. Farmakol. Farm. 2022, 36, 123-128; DOI:10.36290/far.2022.020. Go to original source...
  100. Lemmel E. M.: Brit. J. Rheumatol. 1993, 32, 375-82; DOI: 10.1093/rheumatology/32.5.375. Go to original source...
  101. https://synapse.patsnap.com/article/what-is-clomethiazole-used-forb; staženo 19.12.2024.
  102. https://go.drugbank.com/drugs/DB00568; staženo 19.12.2024.
  103. Barrandell L. B. et al.: Drugs Aging 1996, 8, 299-322; DOI:10.2165/00002512-199608040-00005. Go to original source...
  104. Kapur A.: CNS Drugs 2020, 34, 1045-1062; DOI:10.1007/s40263-020-00758-w. Go to original source...
  105. https://go.drugbank.com/drugs/DB00745; staženo 19.12.2024.
  106. https://drugs.ncats.io/drug/4QBJ98683M; staženo 19.12.2024.
  107. Abdallah A. E.: RSC Adv. 2024, 14, 11057; DOI: 10.1039/d3ra08333k. Go to original source...
  108. https://go.drugbank.com/drugs/DB00981; staženo 19.12.2024.
  109. Charatan F.: Brit. Med. J. 1999, 319, 1154; DOI:10.1136/bmj.319.7218.1154. Go to original source...
  110. Ajenikoko M. K. et al.: IBRO Neurosci Rep. 2022, 19, 64-76; DOI:10.1016/j.ibneur.2022.11.005. Go to original source...
  111. Bodick N. C. et al.: Arch Neurol. 1997, 54, 465-73. DOI:10.1001/archneur.1997.00550160091022. Go to original source...
  112. https://museum.dea.gov/exhibits/online-exhibits/cannabis-coca-and-poppy-natures-addictive-plants/opium- poppy; staženo 12.12.2024.
  113. Hampl F., Rádl S., Paleček J.: Farmakochemie, VŠCHT Praha, 3. vydání, 2015.
  114. www.aimjournal.cz/pdfs/aim/2020/05/04.pdf; staženo 12.12.2024. Go to original source...
  115. https://bpac.org.nz/bpj/2014/july/oxycodone.aspx; staženo 12.12.2024.
  116. chttp://www.drugs.com/monograph/naloxone-hydrochloride.html.
  117. Carbutt C. J.: Current Pharm. Design 2010, 16, 2091-2097; DOI:10.2174/138161210791516459. Go to original source...
  118. Hess L.: Remedia 2013, 23, 298-301; https://www.remedia.cz/rubriky/aktuality/nalmefen-5911/; staženo 12.12.2024.
  119. Gowing L. et al.: Cochrane Database Syst Rev. 2017, 21, CD002025; DOI:10.1002/14651858.CD002025.pub5. Go to original source...
  120. Prommer E.: Palliat Care. 2014, 11, 7-10; DOI: 10.4137/PCRT.S13489. Go to original source...
  121. Gear R. W. et al.: Pain 1999, 83, 339-345; DOI: 10.1016/S0304-3959(99)00119-0. Go to original source...
  122. https://web.archive.org/web/20120125061715/http://www.indro-online.de/historymethadone.htm; staženo 13.12.2024.
  123. Sudebi M. et al.: Biomedicine & Pharmacotherapy 2019, 111, 443-45; DOI:10.1016/j.biopha.2018.12.085. Go to original source...
  124. https://www.drugs.com/monograph/tapentadol.html; staženo 13.12.2024.
  125. Adamson D. W. et al.: Nature 1951, 167,153-4; DOI:10.1038/167153b0. Go to original source...
  126. https://opioidy.weebly.com/oliceridin-a-jeho-analogy.html.
  127. Dhillon S.: Drugs 2024, 84, 717-720; DOI:10.1007/s40265-024-02033-4. Go to original source...
  128. Latta S. K. et al.: Am. J. Therapeutics 2002, 9, 53-68; DOI: 10.1097/00045391-200201000-00010. Go to original source...
  129. https://www.chm.bris.ac.uk/motm/mppp/mppph.htm; staženo 13.12.2024.
  130. Hess L: Remedia 2023, 33, 469-472; https://www.remedia.cz/rubriky/prehledy-nazory-diskuse/kombinace-xylazin-fentanyl-zombie-droga-novy-horor-na-americke-drogove-scene/; staženo 13.12.2024.
  131. Hess L: Remedia 2017, 27, 582-586; https://www.remedia.cz/rubriky/prehledy-nazory-diskuse/carfentanil-nejsilnejsi-znamy-opioid-9418/; staženo 13.12.2024.
  132. https://cs.wikipedia.org/wiki/%C3%9Atok_v_moskevsk%C3%A9m_divadle_na_Dubrovce.
  133. Bodor N. et al.: Med. Res. Rev. 2000, 20, 58-101; DOI:10.1002/(SICI)1098-1128(200001)20:13.0.CO;2-X. Go to original source...
  134. Wikler A. et al.: Psychopharmacologia 1963, 5, 55-76. DOI:10.1007/BF00405575. Go to original source...
  135. Davis D. S. et al.: Clin. Pharm. Therap. 1977, 21, 593-601; DOI:10.1002/cpt1977215593. Go to original source...
  136. Ševčík P. et al.: Praktické lékárenství 2009, 5, 130-134; https://farmaciepropraxi.cz/pdfs/lek/2009/03/06.pdf; staženo 13.12.2024.
  137. Gertler R. et al.: Proceedings 2001, 14, 13-21. DOI:10.1080/08998280.2001.11927725. Go to original source...
  138. Garraffo H. M. et al.: Heterocycles 2009, 79, 207-217; DOI:10.3987/rev-08-sr(d)5. Go to original source...
  139. Bannon A. W. et al.: Science 1998, 279, 77-81; DOI: 10.1126/science.279.5347.77. Go to original source...
  140. Badio B.: Eur. J. Pharm. 1997, 321, 189-94; DOI:10.1016/S0014-2999(96)00939-9. Go to original source...
  141. https://pubchem.ncbi.nlm.nih.gov/compound/Difelikefalin; staženo 13.12.2024.
  142. Monstinar M. R. et al.: Vascular Pharmacology 2019, 113, 1-8; DOI: 10.1016/j.vph.2018.10.008. Go to original source...
  143. https://americanhistory.si.edu/collections/object/nmah_720128.
  144. Sneadar W.: Drug Discovery - History; 2005; John Wiley and Sons; https://books.google.cz/books?id=jglFsz5EJR8C&pg=PA439&redir_esc=y#v=onepage&q&f=false; staženo 16.12.2024.
  145. Brodie B. B. et al.: J. Pharmacol. Exp. Ther. 1948, 94, 22-28. Go to original source...
  146. Horáková Z. et al.: Arzneimittel-Forschung 1958, 8, 229
  147. Muratova J. et al.: Cesko-Slovenska Farmacie 1971, 20, 99-102. Go to original source...
  148. https://go.drugbank.com/drugs/DB00328; staženo 16.12.2024.
  149. https://www.ema.europa.eu/en/documents/other/opinion-committee-medicinal-products-veterinary-use-pursuant-article-303-regulation-ec-no-7262004-risk-vultures-and-other-necrophagous-bird-populations-european-union-conne_en.pdf; staženo 16.12.2024.
  150. https://www.drugs.com/monograph/ketorolac.html.
  151. Suchý D.: Remedia 2015, 25, 16; https://www.remedia.cz/rubriky/prehledy-nazory-diskuse/nimesulid-v-lecbe-akutni-bolesti-6989/; staženo 16.12.2024.
  152. https://www.drugs.com/monograph/meloxicam.html; staženo 16.12.2024.
  153. Vítkovec J.: et al.: Remedia 2005, 15, 158-162; https://www.remedia.cz/rubriky/prehledy-nazory-diskuse/koxiby-a-kardiovaskularni-riziko-722/; staženo 16.12-2024.
  154. https://www.drugs.com/celecoxib.html; staženo 16.12.2024.
  155. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2078665/.
  156. https://hugin.info/134323/R/1156327/223186.pdf.
  157. Zhang S. et al.: J. Med. Chem. 2023, 249, 115151; DOI: 10.1016/j.ejmech.2023.115151. Go to original source...
  158. https://drugs.ncats.io/substance/9ZCS27634Y; staženo 20.12.24.
  159. Jones A. W.: Clinical Pharm. Drug Dev. 2016, 5, 5-12; DOI:10.1002/cpdd.236. Go to original source...
  160. Slater J. W. et al.: Drugs 1999, 57, 31-47; DOI:10.2165/00003495-199957010-00004. Go to original source...
  161. https://neurosciencenews.com/remyelination-optic-nerve-17255/; staženo 20.12.2024.
  162. Giannopoulos P. F. et al.: Molekul. Neurobiol. 2019, 56, 1211-1220; DOI:10.1007/s12035-018-1124-7. Go to original source...
  163. Ho C. Y. et al.: Am. J. Rhinol. 2007, 21, 439-43. DOI:10.2500/ajr.2007.21.3044. Go to original source...
  164. Enna S. J. et al.: xPharm: The Comprehensive Pharmacology Reference; 2008, 1st ed, Elsevier. Go to original source...
  165. Cazzola M. et al.: Pharmacol Rev. 2012, 64, 450-504; DOI:10.1124/pr.111.004580. Go to original source...
  166. Musil J.: Klin. Farmakol. Farm. 2010, 24, 75-79; www.klinickafarmakologie.cz/pdfs/far/ 2010/02/04.pdf.
  167. https://www.drugs.com/pro/aminophylline-injection.html; staženo 29.12.2024.
  168. Waldman H. J.: J. Pain Symptom Management 1994, 9, 434-441. Go to original source...
  169. McCarthy M. L. et al.: Centraly acting myorelaxant 2017, 1133-1141; DOI:10.1007/978-3-319-17900-1_72 Go to original source...
  170. Šťourač P. et al.: Klin. Farmakol. Farm. 2019; 33, 20-23. Go to original source...
  171. https://drugs.ncats.io/drug/HE1ZA4ZBEX; staženo 29.12.2024.
  172. https://go.drugbank.com/drugs/DB06751; staženo 29.12.2024.
  173. Comston A. et al.: Lancet 2002, 359, 1221-1231; DOI: 10.1016/S0140-6736(02)08220-X. Go to original source...
  174. van der Voort P. H. et al.: The Netherlands J. Med. 2016, 74, 276; https://www.njmonline.nl/getpdf.php?id=1743; staženo 29.12.2024.
  175. https://web.archive.org/web/20180620145600/http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001032/WC500069915.pdf.
  176. https://www.webmd.com/multiple-sclerosis/ms-treatment staženo 30.12.2024.
  177. https://www.crohnscolitisfoundation.org/patientsandcaregivers/what-is-crohns-disease/treatment/medication; staženo 30.12.2024.
  178. https://www.drugs.com/condition/plaque-psoriasis.html; staženo 30.12.2024.
  179. Lipsky J. J.: Lancet 1996, 348, 1357-1359. Go to original source...
  180. Barbarino J. M. et al.: Pharmacogenet Genomics 2013, 23, 563-585; DOI: 10.1097/FPC.0b013e328364db84. Go to original source...
  181. https://www.wikiskripta.eu/w/Antikoagulancia; staženo 31.12.2024.
  182. Ridel T. J. et al.: J. Mol. Biol. 1991, 221, 583-601; DOI:10.1016/0022-2836(91)80074-5. Go to original source...
  183. https://go.drugbank.com/drugs/DB01109; staženo 31.12.2024.
  184. Harenberg J.: Thromb Haemost. 2009, 102, 811-5; DOI:10.1160/TH09-08-0555. Go to original source...
  185. Hrubý K.: Praktické lékařství 2006, 1, 24; https://farmaciepropraxi.cz/pdfs/lek/2006/01/06.pdf; staženo 31.12.2024.
  186. Malý R.: Remedia 2008, 18, 331-336; https://www.remedia.cz/rubriky/aktuality/dabigatran-1226/; staženo 31.12.2024.
  187. https://www.manual-cmp.cz/rivaroxaban-xarelto/; staženo 31.12.2024.
  188. https://casopisvnitrnilekarstvi.cz/pdfs/vnl/2016/10/08.pdf; staženo 31.12.2024.
  189. Butlas J. et al.: Remedia 2011, 21, 304-313; https://www.remedia.cz/rubriky/lekove-profily/apixaban-4350/; staženo 31.12.2024.
  190. Ansell J. E.: J. Thromb Thrombolysis 2016, 41, 248-252; DOI:10.1007/s11239-015-1288-1. Go to original source...
  191. Jourdi G. et al.: Front. Cardiovasc. Med. 2022, 9, 1-19; DOI:10.3389/fcvm.2022.805525. Go to original source...
  192. Verstraete M.: Drugs 1985, 29, 236-61; DOI:10.2165/00003495-198529030-00003. Go to original source...
  193. Melichar a kol.: Chemická léčiva, Avicenum, třetí vydání, Praha, 1972.
  194. Kincaid-Smith P.: Med. J. Aust. 1975, 4, 7-9; DOI:10.5694/j.1326-5377.1975.tb140363.x. Go to original source...
  195. https://pubchem.ncbi.nlm.nih.gov/compound/10026; staženo 1.1.2025. 196196 staženo 1.1.2025.
  196. Reisin L. H. et al.: Am J Cardiol. 1988, 61, 2E-3E; DOI:10.1016/0002-9149(88)90079-3. Go to original source...
  197. https://www.webmd.com/heart-disease/heart-disease-calcium-channel-blocker-drugs; staženo 1.1.2025.
  198. Knowles H. J. et al.: Cirkulation research 2004, 95, 162-169; DOI: 10.1161/01.RES.0000134924.89412.70. Go to original source...
  199. https://pubchem.ncbi.nlm.nih.gov/compound/Hydralazine; staženo 1.1.2025.
  200. Sica D. A.: J. Clinical Hypertension 2004, 6, 283-287; DOI:10.1111/j.1524-6175.2004.03585.x. Go to original source...
  201. https://pmc.ncbi.nlm.nih.gov/articles/PMC8094235/pdf/CD005262.pdf.
  202. https://patient.info/heart-health/peripheral-vasodilators; staženo 2.1.2025.
  203. Humphreys D. M. et al.: Int. J. Clin. Pract. 2002, 56, 121-127; https://cmp-manual.wbs.cz/medikace/antiagregancia/pdf/dipyridamol-kardialni_bezpecnost.pdf; staženo 2.1.2025. Go to original source...
  204. Tesař V.: Novinky v nefrologii 2013, 9, 34-36. Go to original source...
  205. Hynie S.: Farmakologie v kostce, 2. vydání, Praha, Triton, 2001; ISBN 80-7254-181-1.
  206. Guzzeta N.: Anesthesia & Analgesia 2007, 105, 312-315; DOI:10.1213/01.ane.0000275185.44796.92. Go to original source...
  207. Wein A. J.: Penn Clinical Manual of Urology, 2007, 479-571; DOI: 10.1016/B978-141603848-1.10014-2. Go to original source...
  208. https://www.thecardiologyadvisor.com/ddi/beta-blockers/; staženo 3.1.2024.
  209. https://www.drugs.com/monograph/timolol.html; staženo 3.1.2024.
  210. https://www.thecardiologyadvisor.com/ddi/beta-blockers/; staženo 3.1.2024.
  211. Doležal T.: Remedia 2002, 12, 158-163; https://www.remedia.cz/rubriky/lekove-profily/celiprololum-967/; staženo 3.1.2025.
  212. Jež J. et al.: Kardiol. Rev. Int. Med. 2010, 12, 28-31; https://www.kardiologickarevue.cz/casopisy/kardiologicka-revue/2010-1/carvedilol-v-lecbe-kardiovaskularnich-onemocneni-32084.
  213. https://www.rxlist.com/beta_blockers/drug-class.htm.
  214. do Vale G. T. et al.: Curr Hypertens Rev. 2019, 15, 22-31; DOI:10.2174/1573402114666180918102735. Go to original source...
  215. Widimský J.: Remedia 2016, 26; https://www.remedia.cz/rubriky/aktuality/nebivolol-7713/; staženo 3.1.2024.
  216. Schäfer S. G. et al.: Ann N Y Acad Sci. 1995, 12, 659-72; DOI:10.1111/j.1749-6632.1995.tb32460.x. Go to original source...
  217. https://www.drugs.com/clonidine.html; staženo 3.1.2025.
  218. Fenton C. et al.: Drug 2006, 66, 477-96; DOI:10.2165/00003495-200666040-00006. Go to original source...
  219. Souček M. et al.: Remedia 2014, 4,; https://www.remedia.cz/rubriky/lekove-profily/rilmenidinum-772/; staženo 3.1.2025.
  220. https://www.wikiskripta.eu/w/Renin; staženo 3.1.2025.
  221. Patočka J. et al.: Environmental Tox. Pharm. 2020, 79, 1-6; DOI: 10.1016/j.etap.2020.103400. Go to original source...
  222. Táborsky M. et al.: Kardiol. Rev. Int. Med. 2006, 8, 193-197; https://www.kardiologickarevue.cz/.casopisy/kardiologicka-revue/2006-4/nova-antiarytmika-v-lecbe-fibrilace-sini-31956; staženo 3.1.2025.
  223. Hollman A.: British Heart J. 1991, 66, 301; DOI:10.1136/hrt.66.4.301. Go to original source...
  224. Leflerová K.: Remedia 2017, 27, 494-497; https://www.remedia.cz/rubriky/prehledy-nazory-diskuse/propafenon-9305/; staženo 3.1.2025.
  225. https://www.drugs.com/monograph/flecainide-acetate.html; staženo 3.1.2025.
  226. Petrová J. et al.: https://www.e-coretvasa.cz/pdfs/cor/2019/06/08.pdf; staženo 6.1.2025.
  227. Čihák R.: Remedia 2006, 14, 443-446; https://www.remedia.cz/rubriky/aktuality/dronedaron-1032/; staženo 6.1.2025.
  228. https://www.sciencedirect.com/topics/medicine-and-dentistry/azimilide; staženo 3.1.2025.
  229. https://www.uptodate.com/contents/medications-for-angina-beyond-the-basics; staženo 6.1.2025.
  230. Bruno R. R. et al.: Pharmacol. Therapeutics 2022, 240, 108230; DOI:10.1016/j.pharmthera.2022.108230 Go to original source...
  231. Hutyra M. et al.: Interv. Akut. Kardiol. 2017, 16, 63-68. Go to original source...
  232. https://www.wikiskripta.eu/w/Diuretika.
  233. Eknoyan G.: Diuretic Agents, 1997, Elsevier; DOI: 10.1016/B978-012635690-8/50002-5; ISBN 978-0-12-635690. Go to original source...
  234. Špác J. et al.: Medicína pro praxi 2010, 7, 105-110; https://www.medicinapropraxi.cz/pdfs/med/2010/ 03/03.pdf; staženo 7.1.2025.
  235. Donato V. et al.: Cellular Physiology and Biochemistry 2014, 33, 1369-1388; DOI: 10.1159/000358704. Go to original source...
  236. Klotz L.: BJU Int. 2005, 956-957; DOI:10.1111/j.1464-410X.2005.05797.x. Go to original source...
  237. https://en.wikipedia.org/wiki/Giles_Brindley; staženo 7.1.2025.
  238. Klečka J.: Remedia 2014, 24, 384-386; https://www.remedia.cz/rubriky/prehledy-nazory-diskuse/tadalafil-u-pacientu-s-mikcnimi-symptomy-dolnich-mocovych-cest-6750/; staženo 7.1.2025.
  239. Jiwrajka M. et al.: Aust Prescr. 2018, 41, 150-153; DOI:10.18773/austprescr.2018.045. Go to original source...
  240. Bettarello A.: Dig. Dis. Sci. 1985, 30 (11 Suppl), 36S-42S; DOI:10.1007/BF01309383. Go to original source...
  241. Inatomi N. et al.: Pharmacol Ther. 2016, 168, 12; DOI:10.1016/j.pharmthera.2016.08.001. Go to original source...
  242. Tůma J.: Urol. praxi 2021; 22, 115-119; https://www.urologiepropraxi.cz/pdfs/uro/2021/ 03/02.pdf; staženo 8.1.2025. Go to original source...
  243. https://www.ema.europa.eu/en/medicines/human/EPAR/obgemsa; staženo 8.1.2025.
  244. Rodgers R. J. et al.: Dis Model Mech. 2012, 5, 621-626; DOI:10.1242/dmm.009621. Go to original source...
  245. https://www.rivuspharma.com/; staženo 8.1.2025.
  246. Rádl S.: Příběhy spojené s objevy nových léčiv, VŠCHT Praha; 2023.
  247. MacGilbeny M. A. et al.: PLOS Pathogens 2018, 14, e1007188; DOI:10.1371/journal.ppat. 1007188. Go to original source...
  248. Roila F. et al.: Ann Oncol. 2006,17, Suppl 2, 96-100; DOI:10.1093/annonc/mdj936. Go to original source...
  249. https://pubchem.ncbi.nlm.nih.gov/compound/Netupitant; staženo 8.1.2025.
  250. Kleinsorge H.: Exp Clin Endocrinol Diabetes. 1998, 106, 149-51; DOI:10.1055/s-0029-1211968. Go to original source...
  251. Bailey C J.: Diabetologia 2017, 60, 1566-1576; DOI:10.1007/s00125-017-4318-z. Go to original source...
  252. https://www.drugs.com/monograph/glimepiride.html; staženo 8.1.2025.
  253. Gale E. A.: Lancet 2001, 357, 1870-1875; DOI:10.1016/S0140-6736(00)04960-6. Go to original source...
  254. Natarajan P. et al.: J. Am. College Cardiology 2010, 55, 1283-1299; DOI:10.1016/j.jacc.2010.01.008. Go to original source...
  255. Adamíková A. et al.: Remedia 2014, 24, 68-72; https://www.remedia.cz/rubriky/lekove-profily/lixisenatid- 6317/; staženo 8.1.2025.
  256. Bohannon N.: Postgrad Med. 2009, 121, 40-45; DOI:10.3810/pgm.2009.01.1953. Go to original source...
  257. Ehrenkranz J. R. L et al.: Diabetes Metab Res Rev 2005, 21, 31-38; DOI:10.1002/dmrr.532. Go to original source...
  258. Isaji M.: Kidney Int. 2011, 79, Supl. 120, 14-19; DOI: 10.1038/ki.2010.511. Go to original source...
  259. Bultas J.: Remedia 2013, 23, 143-150; https://www.remedia.cz/rubriky/prehledy-nazory-diskuse/vzajemne-srovnani-statinu-z-pohledu-farmakologa-5656/; staženo 9.1.2025.
  260. Barter P. J. et al.: Clinical Therap. 2015, 37, 2716-2731; DOI:10.1016/j.clinthera.2015.07.021. Go to original source...
  261. Lincoff A. M. et al.: J. Am. Coll. Cardiol. 2024, 84, 152-162; DOI:10.1016/j.jacc.2024.04.048. Go to original source...
  262. Taylor J. B. et al.: Comprehensive medicinal chemistry II, 2nd ed; Elsevier Science, 2006, ISBN 9780080450445.
  263. Higgins J. A. et al.: The Equine Manual, 2nd ed., Elsevier Ltd., 2006; ISBN 978-0-7020-2769-7.
  264. Henk J. M. et al.: Radiotherapy Oncology 2003, 66, 65-70; DOI:10.1016/S0167-8140(02)00284-0. Go to original source...
  265. https://errolozdalga.com/medicine/pages/OtherPages/AntibioticReview.ChanuRhee.html; staženo 14.2.2025.
  266. Davison A. N.: Biochem. J. 1957, 67, 316-322. DOI:10.1042/bj0670316. Go to original source...
  267. Borelli C. et al.: Chemotherapy 2008, 54, 245-59; DOI:10.1159/000142334. Go to original source...
  268. Berney D. et al.: Helv. Chim. Acta 1978, 61, 1262; DOI:10.1002/hlca.19780610409. Go to original source...
  269. Wiederhold N. P.: J. Fungi 2020, 6, 122; DOI:10.3390/jof6030122. Go to original source...
  270. Bruliková L. et al.: Current Med. Chem. 2012, 19, 364-385; DOI:10.2174/092986712803414295. Go to original source...
  271. Koubková L.: Remedia 2009, 19, 331, 335; https://www.remedia.cz/rubriky/lekove-profily/pemetrexed- 2916/; staženo 27.1.2025.
  272. Xu X. H. et al.: J. Nat. Prod. 2003, 66, 285-288; DOI:10.1021/np020034f. Go to original source...
  273. Rathkopf D. E. et al.: Annals Oncology 2024, 36, 76 - 88; DOI:10.1016/j.annonc.2024.09.005. Go to original source...
  274. https://www.remedia.cz/rubriky/aktuality/vismodegib-cilena-lecba-inoperabilniho-bazocelularniho-karcinomu-6630/.
  275. Lee S. J. et al.: Sci Rep. 2021, 11, 10145; DOI:10.1038/s41598-021-89238-9. Go to original source...
  276. Seniutkin O. et al.: Toxicol. Appl. Pharmacol. 2018, 339,1-9; DOI: 10.1016/j.taap.2017.11.024. Go to original source...
  277. Cho M. E. et al.: Expert Opin. Investig. Drugs 2010, 19, 275-83; DOI:10.1517/13543780903501539. Go to original source...
  278. Niu L. et al.: J. Biol. Chem. 2019, 294, 18099-18108; DOI:10.1074/jbc.RA119.010732. Go to original source...
  279. Zhang Y. X.: Clin. Exp. Obstet. Gynecol. 2016, 43, 350-3. Go to original source...
  280. Cremlyn R..: Pesticidy, SNTL, 1. vyd., 244 s, Praha 1985.
  281. Ware G. G. et al.: Introduction to Insecticides, 4th ed., Meister Media Worldwide, 2004; https://ipmworld.umn.edu/ware-intro-insecticides; staženo 23.01.25.
  282. Zbirovský M, Myška J: Insekticidy, fungicidy, rodenticidy; ČSAV, 1957.
  283. https://pubchem.ncbi.nlm.nih.gov/compound/Thanite; Staženo: 23.1.2025.
  284. https://www.eurekalert.org/news-releases/541533; staženo 23.1.2025.
  285. https://pubs.acs.org/doi/10.1021/acs.est.7b06388;staženo 23.1.2025.
  286. Pener P. M. et al.: Adv. Insect Physiology 2012, 43, 1-162; DOI:10.1016/B978-0-12-391500-9.00001-2. Go to original source...
  287. Merzendorfen H.: Insect Sci. 2013, 121-38; DOI:10.1111/j.1744-7917.2012.01535.x. Go to original source...
  288. Jedlička P.: Juvenoidy a juvenogeny - možnosti jejich využití v ochraně rostlin před herbivorním hmyzem; Disertační práce, Karlova Univerzita Praha, 2008.
  289. Watt B. E. et al.: Toxicol. Rev. 2005, 24, 259-69; DOI:10.2165/00139709-200524040-00005. Go to original source...
  290. https://www.msdvetmanual.com/toxicology/rodenticide-poisoning/cholecalciferol-vitamin-d3-poisoning-in- animals.
  291. Proudfoot, A. T. et al.: Toxicological Reviews 2006, 25, 213-219. doi:10.2165/00139709-200625040-00002. Go to original source...
  292. https://www.chemicalpapers.com/file_access.php?file=49-10a586.pdf.
  293. https://www.smolecule.com/products/s1490719.
  294. Gupta R. C.: Veterinary Tox. 2007, 548-560; DOI: 10.1016/B978-012370467-2/50146-2. Go to original source...
  295. https://www.haz-map.com/Agents/6918; staženo 23.1.2025.
  296. Fusi F. et al.: Cells 2024, 13, 788; DOI:10.3390/cells13090788. Go to original source...
  297. Decino T. J. et al.: J. Wildlife Management 1966, 30, 249-253; DOI:10.230/3797809. Go to original source...
  298. https://www.avitrol.com/avitrol-a-chemical-agent-to-remove-pest-birds.html; staženo 24.1.2025.
  299. https://de.wikipedia.org/wiki/Herbicide_Resistance_Action_Committee.
  300. https://pmc.ncbi.nlm.nih.gov/articles/PMC4441250/.
  301. Jursík M. et al.: Listy cukrovarnické a řepařské 2011, 127, 88; http://www.cukr-listy.cz/on_line/2011/PDF/88-92.pdf.
  302. Jursík M. et al.: Listy cukrovarnické a řepařské 2010, 126, 48; http://www.cukr-listy.cz/on_line/2010/PDF/48-54.PDF.
  303. https://herbicidesymptoms.ipm.ucanr.edu/MOA/ALS_or_AHAS_inhibitors/; staženo 25.1.2025.
  304. www.sciencedaily.com/releases/2024/07/240710195355.htm; staženo 22.7.2024.
  305. Pitschmann V.: Chemici v laboratoři a na bitevním poli, Naše vojsko, 2012; ISBN 978-80-206-1298-4.
  306. Pitschmann V.: Chemická válka ve věku atomu a DNA; Naše vojsko, 2016; ISBN 978-80-206-1632-6.
  307. Kobliha Z. et al.: Chemie bojových chemických látek, Univerzita obrany, Brno, 2024.
  308. Kobliha Z. et al.: Chemické zbraně, Univerzita obrany, Brno, 2022.
  309. https://web.archive.org/web/20061112085443/http://www.mitretek.org/AShortHistoryOfTheDevelopmentOfNerveGases.htm.
  310. Guthrie F.: Q. J. Chem. Soc. 1860, 109-126; DOI 10.1039/QJ8601200109. Go to original source...
  311. Sawyer T. W. et al.: Fundamental Applied Toxicology 1991, 17, 208-214. Go to original source...
  312. Abou-Donia M. B. et al.: Crit. Rev. Toxicol. 2016, 46, 845-875; DOI: 10.1080/10408444.2016.1220916. Go to original source...
  313. Bajgar J. et al.: Acta Biol Med Ger. 1976, 35, 479-84.
  314. https://lib.unob.cz/UNOB_CZ/FVZ/K304/PREZENTACE/BOL_zneuzitelne.pdf.
  315. Wang, B. et al.: Nat Commun 2023, 14, 2241; DOI:10.1038/s41467-023-37714-3. Go to original source...
  316. Patočka J. et al.: Mil. Med. Sci. Lett. 2011, 80, 129-139; DOI:10.31482/mmsl.2011.019. Go to original source...
  317. Aráoz R. et al.: Toxicon 2010, 56, 813-28; DOI: 10.1016/j.toxicon.2009.07.036. Go to original source...
  318. Chan T. Y. K.: Clinical Toxicology 2009, 47, 279-285; DOI:10.1080/15563650902904407. Go to original source...
  319. Volfová A. et al.: Mil. Med. Sci. Lett. 2003, 72, 110-113; https://mmsl.cz/pdfs/mms/2003/03/07.pdf; staženo 16.12.2024.
  320. Dasgeb B. et al.: British J. Dermatology 2018, 178, 350-356; DOI:10.1111/bjd.15896. Go to original source...
  321. fatal_case_of_autumn_crocus_poisoning_2010.pdf; staženo 16.12.2024.
  322. Wang S. Y. et al.: Chanels 2007, 1, 179-188; DOI:10.4161/chan.4437. Go to original source...
  323. https://www.toxicology.cz/modules.php?name=News&file=print&sid=606; staženo 16.12.2024.
  324. Schep L. J. et al.: Clinical Toxicology 2009, 47, 270-278; DOI:10.1080/15563650902904332. Go to original source...
  325. Lin M. et al.: J. Ethnopharmacology 2016, 193; DOI:10.1016/j.jep.2016.09.052. Go to original source...
  326. L. Escrivá et al.: Food Chem. Tox. 2015, 78, 185-206; DOI:10.1016/j.fct.2015.02.005 Go to original source...
  327. Chen P. H. et al.: Am. J. Ind. Med. 1984, 5, 133-45. Go to original source...
  328. https://pubs.acs.org/doi/pdf/10.1021/es1013664.
  329. https://www.atsdr.cdc.gov/toxprofiles/tp32.pdf.
  330. https://pubchem.ncbi.nlm.nih.gov/compound/6511.